| NAME |
ELAGOLIX/ESTRADIOL/NORETHINDRONE CAP,ORAL WEEKLY PACK |
| VA GENERIC NAME |
ELAGOLIX/ESTRADIOL/NORETHRINDRONE |
| DOSAGE FORM |
CAP,ORAL |
| FDA MED GUIDE |
Elagolix-Estradiol-Norethindrone_Elagolix_Cap_(Oriahnn)_(2020).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
ELAGOLIX/ESTRADIOL/NORETHRINDRONE CAP,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2020-06-11 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
ORIAHNN ORAL CAP WEEKLY PACK |
| VA PRODUCT IDENTIFIER |
O0417 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
PKT |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4039452 |
| EFFECTIVE DATE/TIME |
-
- 2020-06-11 00:00:00
- STATUS: ACTIVE
|